NeoLogics Bioscience Co., Ltd was established in Suzhou in 2019. Currently, it is a preclinical-stage biotech company specializing in biologics for immune modulation. Its disease areas include cancer, autoimmune, and inflammation.

Disease Domain	Count

Neoplasms	7
Immune System Diseases	2
Hemic and Lymphatic Diseases	1

Top 5 Drug Type	Count

Monoclonal antibody	5
Bispecific antibody	3

Top 5 Target	Count

ADCY1(Brain adenylate cyclase 1)	1
TIM3(Hepatitis A virus cellular receptor 2)	1
CEACAM1 x VEGF	1
PD-1 x TIM3	1
KLRG1(killer cell lectin like receptor G1)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 01 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

NB-002(NeoLogics Bioscience) ( TIM3 )	Metastatic Solid Tumor More	Phase 1
NB005-1 ( KLRG1 )	Neoplasms More	Preclinical
NB-303	Solid tumor More	Preclinical
NB-203 ( CEACAM1 x VEGF )	Neoplasms More	Preclinical
NB- 202 ( PD-1 x TIM3 )	Neoplasms More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis